Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amalia A Sofianidi

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|May 27, 2026
CAFs and Endocrine Therapy Resistance in Hormone Receptor-Positive Breast CancerAmalia A Sofianidi, Vaia K Stafyla, Flora Zagouri
Cancers|May 14, 2025
The Attractiveness of B7-H3 as a Target for Lung Cancer TreatmentKostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou
Antioxidants (Basel, Switzerland)|August 28, 2025
Reactive Oxygen Species and the Lung Cancer Tumor Microenvironment: Emerging Therapeutic OpportunitiesKostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou
Nutrients|May 25, 2024
Anthocyanins in Non-Small Cell Lung Cancer (NSCLC) Treatment and PreventionKostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou
Journal of Cellular and Molecular Medicine|April 12, 2024
YAP/TAZ-TEAD signalling axis: A new therapeutic target in malignant pleural mesotheliomaKostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou
International Journal of Molecular Sciences|February 27, 2026
Diagnosis of Lung Diseases in the Artificial Intelligence EraKostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou
Current Oncology Reports|June 22, 2026
Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple DiseasesAmalia A Sofianidi, Evangelia Panagodimou, Emmanouil Kalampokas, et al.
Journal of Cellular and Molecular Medicine|July 14, 2026
ROS and Antioxidants: Prospective Therapeutic Options in CancerKostas A Papavassiliou, Amalia A Sofianidi, Angeliki Margoni, et al.
International Journal of Molecular Sciences|March 28, 2026
Biologically Informed Treatment Approaches Toward Personalized Therapeutic Strategies in Lung CancerKostas A Papavassiliou, Amalia A Sofianidi, Angeliki Margoni, et al.
Journal of Cellular and Molecular Medicine|April 5, 2025
The IGF Signalling Axis in Lung Cancer: Clinical Significance and Therapeutic ChallengesKostas A Papavassiliou, Amalia A Sofianidi, Kyriaki Cholidou, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|May 27, 2026
CAFs and Endocrine Therapy Resistance in Hormone Receptor-Positive Breast CancerAmalia A Sofianidi, Vaia K Stafyla, Flora Zagouri
Cancers|May 14, 2025
The Attractiveness of B7-H3 as a Target for Lung Cancer TreatmentKostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou
Antioxidants (Basel, Switzerland)|August 28, 2025
Reactive Oxygen Species and the Lung Cancer Tumor Microenvironment: Emerging Therapeutic OpportunitiesKostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou
Nutrients|May 25, 2024
Anthocyanins in Non-Small Cell Lung Cancer (NSCLC) Treatment and PreventionKostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou
Journal of Cellular and Molecular Medicine|April 12, 2024
YAP/TAZ-TEAD signalling axis: A new therapeutic target in malignant pleural mesotheliomaKostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou
International Journal of Molecular Sciences|February 27, 2026
Diagnosis of Lung Diseases in the Artificial Intelligence EraKostas A Papavassiliou, Amalia A Sofianidi, Athanasios G Papavassiliou
Current Oncology Reports|June 22, 2026
Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple DiseasesAmalia A Sofianidi, Evangelia Panagodimou, Emmanouil Kalampokas, et al.
Journal of Cellular and Molecular Medicine|July 14, 2026
ROS and Antioxidants: Prospective Therapeutic Options in CancerKostas A Papavassiliou, Amalia A Sofianidi, Angeliki Margoni, et al.
International Journal of Molecular Sciences|March 28, 2026
Biologically Informed Treatment Approaches Toward Personalized Therapeutic Strategies in Lung CancerKostas A Papavassiliou, Amalia A Sofianidi, Angeliki Margoni, et al.
Journal of Cellular and Molecular Medicine|April 5, 2025
The IGF Signalling Axis in Lung Cancer: Clinical Significance and Therapeutic ChallengesKostas A Papavassiliou, Amalia A Sofianidi, Kyriaki Cholidou, et al.
Pageof 3